These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7935094)

  • 21. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
    Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
    J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease.
    Perrone-Filardi P; Bacharach SL; Dilsizian V; Marin-Neto JA; Maurea S; Arrighi JA; Bonow RO
    J Am Coll Cardiol; 1994 Mar; 23(3):608-16. PubMed ID: 8113542
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of planar fluorine-18-FDG imaging after recent myocardial infarction to assess myocardial viability.
    Huitink JM; Visser FC; van Lingen A; Groeneveld AB; Bax JJ; van Leeuwen GR; Visser GM; Van Loon MJ; Teule GJ; Visser CA
    J Nucl Med; 1995 Jun; 36(6):975-81. PubMed ID: 7769455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose.
    Tamaki N; Ohtani H; Yamashita K; Magata Y; Yonekura Y; Nohara R; Kambara H; Kawai C; Hirata K; Ban T
    J Nucl Med; 1991 Apr; 32(4):673-8. PubMed ID: 2013806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 18F-2-deoxyglucose deposition and regional flow in pigs with chronically dysfunctional myocardium. Evidence for transmural variations in chronic hibernating myocardium.
    Fallavollita JA; Perry BJ; Canty JM
    Circulation; 1997 Apr; 95(7):1900-9. PubMed ID: 9107179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Functional/metabolic CAD diagnosis: arbutamine-RNV, stress-Echo, Tl-SPECT and gated FDG-PET].
    Adams S; Baum RP; Scholz M; Zeiher AM; Hör G
    Nuklearmedizin; 1997 Jun; 36(4):146-9. PubMed ID: 9289701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
    Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
    J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.
    Lucignani G; Paolini G; Landoni C; Zuccari M; Paganelli G; Galli L; Di Credico G; Vanoli G; Rossetti C; Mariani MA
    Eur J Nucl Med; 1992; 19(10):874-81. PubMed ID: 1451704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional thallium uptake in irreversible defects. Magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium.
    Dilsizian V; Freedman NM; Bacharach SL; Perrone-Filardi P; Bonow RO
    Circulation; 1992 Feb; 85(2):627-34. PubMed ID: 1735157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of assessing regional myocardial uptake of 18F-fluorodeoxyglucose using single photon emission computed tomography.
    Bax JJ; Visser FC; van Lingen A; Huitink JM; Kamp O; van Leeuwen GR; Visser GW; Teule GJ; Visser CA
    Eur Heart J; 1993 Dec; 14(12):1675-82. PubMed ID: 8131767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of myocardial perfusion and viability with technetium-99m methoxyisobutylisonitrile and thallium-201 rest redistribution in chronic coronary artery disease.
    Rossetti C; Landoni C; Lucignani G; Huang G; Bartorelli AL; Guazzi MD; Margonato A; Chierchia S; Galli L; Savi A
    Eur J Nucl Med; 1995 Nov; 22(11):1306-12. PubMed ID: 8575482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of ischemic and hibernating myocardium: feasibility of post-exercise F-18 deoxyglucose positron emission tomography.
    Marwick TH; MacIntyre WJ; Salcedo EE; Go RT; Saha G; Beachler A
    Cathet Cardiovasc Diagn; 1991 Feb; 22(2):100-6. PubMed ID: 2009557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans.
    Choi Y; Brunken RC; Hawkins RA; Huang SC; Buxton DB; Hoh CK; Phelps ME; Schelbert HR
    Eur J Nucl Med; 1993 Apr; 20(4):308-18. PubMed ID: 8491223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: an alternative for determining myocardial viability.
    Sandler MP; Patton JA
    J Nucl Cardiol; 1996; 3(4):342-9. PubMed ID: 8799254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myocardial F-18 fluorodeoxyglucose imaging by SPECT.
    Bax JJ; Visser FC; van Lingen A; Visser CA; Teule GJ
    Clin Nucl Med; 1995 Jun; 20(6):486-90. PubMed ID: 7648727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple quantification of regional myocardial uptake of fluorine-18-deoxyglucose in the fasting condition.
    Tamaki N; Yonekura Y; Kawamoto M; Magata Y; Sasayama S; Takahashi N; Nohara R; Kambara H; Kawai C; Konishi J
    J Nucl Med; 1991 Nov; 32(11):2152-7. PubMed ID: 1941154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
    Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative performance of gated perfusion SPECT wall thickening, delayed thallium uptake, and F-18 fluorodeoxyglucose SPECT in detecting myocardial viability.
    DePuey EG; Ghesani M; Schwartz M; Friedman M; Nichols K; Salensky H
    J Nucl Cardiol; 1999; 6(4):418-28. PubMed ID: 10461609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI].
    Büll U; Foroutan Y; Hellwig D; Kaiser HJ; Schulz G; Sabri O; Schreckenberger M; vom Dahl J
    Nuklearmedizin; 1995 Dec; 34(6):223-8. PubMed ID: 8596738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The comparison of 2-18F-2-deoxyglucose and 15-(ortho-123I-phenyl)-pentadecanoic acid uptake in persisting defects on thallium-201 tomography in myocardial infarction.
    Henrich MM; Vester E; von der Lohe E; Herzog H; Simon H; Kuikka JT; Feinendegen LE
    J Nucl Med; 1991 Jul; 32(7):1353-7. PubMed ID: 2066789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.